{"transactions":[{"id":744289,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:42:41.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000204","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000204/form4.xml","form_type":"4"}},{"id":744288,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:42:41.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000204","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000204/form4.xml","form_type":"4"}},{"id":748734,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:25.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":191842,"source":{"system":"sec-edgar","filing":"0001788981-26-000002","document":"wk-form4_1780691122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898126000002/wk-form4_1780691122.xml","form_type":"4"}},{"id":1111118,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:50:17.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000228","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000228/form4.xml","form_type":"4"}},{"id":1120392,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:04:52.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":132141,"source":{"system":"sec-edgar","filing":"0001628280-25-029974","document":"wk-form4_1749240285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029974/wk-form4_1749240285.xml","form_type":"4"}},{"id":1487591,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:54:29.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":15695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":82345,"source":{"system":"sec-edgar","filing":"0001628280-24-027333","document":"wk-form4_1717793661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024027333/wk-form4_1717793661.xml","form_type":"4"}},{"id":1489600,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:47:59.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000288","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000288/form4.xml","form_type":"4"}},{"id":1516507,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T21:48:02.000Z","date":"2024-05-13","kind":"sale","planned":false,"acquired":false,"shares":6200,"price":25.3,"value":156860.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.30 to $25.39, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":66650,"source":{"system":"sec-edgar","filing":"0001788981-24-000002","document":"wk-form4_1715809662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898124000002/wk-form4_1715809662.xml","form_type":"4"}},{"id":1860141,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:07:15.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":38250,"derivative":{"exercise_price":5.38,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":38250},"source":{"system":"sec-edgar","filing":"0001610717-23-000120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071723000120/form4.xml","form_type":"4"}},{"id":1870914,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:07:48.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":15151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":72850,"source":{"system":"sec-edgar","filing":"0001788981-23-000002","document":"wk-form4_1685743652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898123000002/wk-form4_1685743652.xml","form_type":"4"}},{"id":2246011,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T21:26:51.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":17275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":57699,"source":{"system":"sec-edgar","filing":"0001628280-22-016220","document":"wf-form4_165429159331764.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022016220/wf-form4_165429159331764.xml","form_type":"4"}},{"id":2411391,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-05T01:19:52.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from February 2, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":54000,"derivative":{"exercise_price":12.44,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001567619-22-002564","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761922002564/doc1.xml","form_type":"4"}},{"id":2681730,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T23:02:42.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant."}],"balance_after":40424,"source":{"system":"sec-edgar","filing":"0001788981-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898121000002/edgardoc.xml","form_type":"4"}},{"id":2955662,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-07T22:24:06.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":15889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":27576,"source":{"system":"sec-edgar","filing":"0001788981-20-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898120000003/edgardoc.xml","form_type":"4"}},{"id":3350244,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T18:17:50.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":11687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":11687,"source":{"system":"sec-edgar","filing":"0001788981-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898119000004/edgardoc.xml","form_type":"4"}}]}